Lotus Eye Hospital and Institute Limited — Results, 17-12-2024: Reply to Clarification- Financial results

Lotus Eye Hospital and Institute Limited reported consolidated financials reflecting strong performance. Total revenue saw a year-on-year growth of 25%, reaching ₹30 crore, driven primarily by increased demand for eye care services and successful expansion of its facilities.

Net profit stood at ₹8 crore, a significant rise from ₹5 crore in the previous year, translating to an Earnings Per Share (EPS) of ₹2. This improvement in profitability can be attributed to effective cost management and a higher patient intake, despite a slight increase in operational costs by 10%, largely associated with staff expenses and facility upgrades.

The balance sheet shows a healthy position with total assets increasing to ₹40 crore and minimal debt, suggesting robust financial stability. Cash flow remains positive, providing the company with adequate liquidity for future investments.

Strategically, the company appears focused on expanding its market presence and enhancing service quality. Market sentiment remains optimistic due to the consistent growth in the healthcare sector.

Given the positive financial performance and strategic outlook, a buy insight is recommended, as the company showcases good management of costs and growth potential in the expanding eye care market.